Yu-Ming Chuang

Yu-Ming Chuang

Auto-generated profile, based on publicly available information

Yu-Ming Chuang

University of Lausanne 1 Department of Fundamental Oncology Lausanne

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2024 in Science Immunology
Verified
Journal Article
Closed access
ABAlessio Bevilacqua
Alessio Bevilacqua
FFFabien Franco
Fabien Franco
YLYa-Ting Lu
Ya-Ting Lu
NRNabil Rahiman
Nabil Rahiman
KKKung-Chi Kao
Kung-Chi Kao
PHPing-Chih Ho
Ping-Chih Ho
The formation of memory T cells is a fundamental feature of adaptative immunity, allowing the establishment of long-term protection against pathogens. Although emerging evidence suggests that metabolic reprogramming is crucial for memory T cell differentiation and survival, the underlying mechanisms that drive metabolic rewiring in memory T cells remain unclear. Here, we found that up-regulation of the nuclear receptor peroxisome proliferator–activated receptor β/δ (PPARβ/δ) instructs the metabolic reprogramming that occurs during the establishment of central memory CD8 + T cells. PPARβ/δ-regulated changes included suppression of aerobic glycolysis and enhancement of oxidative metabolism and fatty acid oxidation. Mechanistically, exposure to interleukin-15 and expression of T cell factor 1 facilitated activation of the PPARβ/δ pathway, counteracting apoptosis induced by antigen clearance and metabolic stress. Together, our findings indicate that PPARβ/δ is a master metabolic regulator orchestrating a metabolic switch that may be favorable for T cell longevity.

16 July 2025 in Journal of Experimental Medicine
Verified
Journal Article
Closed access
XLXiaoyun Li
Xiaoyun Li
SMSofie Hedlund Møller
Sofie Hedlund Møller
JPJaeoh Park
Jaeoh Park
YCYu-Ming Chuang
Yu-Ming Chuang
PHPei-Chun Hsueh
Pei-Chun Hsueh
PHPing-Chih Ho
Ping-Chih Ho
In the tumor microenvironment (TME), cancer-associated fibroblasts (CAFs) play a crucial role in promoting tumor progression by creating an immunosuppressive environment through cytokine secretion and antigen presentation. While previous studies have demonstrated that CAFs exhibit distinct metabolic profiles compared with normal fibroblasts, it remains unclear how these metabolic programs influence the immune landscape within tumors and which factors drive metabolic reprogramming in CAFs. Here, we found that glutamine synthesis by CAFs promotes the polarization of pro-tumorigenic tumor-associated macrophages (TAMs) and supports tumor growth by altering TAM composition, highlighting the pivotal role of CAFs in shaping the immunosuppressive TME. Mechanistically, we found that tumor-derived palmitic acid activates a signaling cascade involving TLR4, Syk, and NF-κB in fibroblasts, leading to inflammatory CAF polarization and IL-6–induced glutamine synthesis. These findings uncover a novel metabolic symbiosis whereby tumor cells manipulate TAM polarization through CAF-mediated glutamine metabolism, presenting potential therapeutic targets for cancer immunotherapy.